EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
   3.4.22.B49 | COVID-19 |
33503446 |
Multi-organ proteomic landscape of COVID-19 autopsies. |
causal interaction
unassigned |
4
0 |
| 3.4.22.B49 | Endometritis |
31711690 |
Endometrial expression of various genes (ISGs, PPARs, RXRs and MUC1) on day 16 post-ovulation in repeat breeder cows, with or without subclinical endometritis. |
diagnostic usage
ongoing research
unassigned |
3
1
0 |
| 3.4.22.B49 | Endometritis |
33920430 |
mRNA Expressions of Candidate Genes in Gestational Day 16 Conceptus and Corresponding Endometrium in Repeat Breeder Dairy Cows with Suboptimal Uterine Environment Following Transfer of Different Quality Day 7 Embryos. |
diagnostic usage
ongoing research
unassigned |
3
1
0 |
| 3.4.22.B49 | Fascioliasis |
9574785 |
Immunodiagnosis of Fasciola hepatica infection (fascioliasis) in a human population in the Bolivian Altiplano using purified cathepsin L cysteine proteinase. |
diagnostic usage
ongoing research
therapeutic application
unassigned |
3
2
1
0 |
| 3.4.22.B49 | Fascioliasis |
10344647 |
Short report: Immunodiagnosis of human fascioliasis using recombinant Fasciola hepatica cathepsin L1 cysteine proteinase. |
diagnostic usage
ongoing research
therapeutic application
unassigned |
4
4
1
0 |
| 3.4.22.B49 | Fascioliasis |
15728871 |
Serodiagnosis of human fascioliasis by a cystatin capture enzyme-linked immunosorbent assay with recombinant Fasciola gigantica cathepsin L antigen. |
diagnostic usage
ongoing research
therapeutic application
unassigned |
1
4
1
0 |
| 3.4.22.B49 | Fascioliasis |
16168617 |
Potent epitopes derived from Fasciola gigantica cathepsin L1 in peptide-based immunoassay for the serodiagnosis of human fascioliasis. |
ongoing research
unassigned |
2
0 |
| 3.4.22.B49 | Fascioliasis |
29679594 |
Design and synthesis of a new peptide derived from Fasciola gigantica cathepsin L1 with potential application in serodiagnosis of fascioliasis. |
unassigned |
0 |
| 3.4.22.B49 | Glioma |
23201138 |
Viability screen on pediatric low grade glioma cell lines unveils a novel anti-cancer drug of the steroid biosynthesis inhibitor family. |
causal interaction
unassigned |
1
0 |
| 3.4.22.B49 | Infections |
10425237 |
Immune responses of cattle to experimental anti-Fasciola hepatica vaccines. |
therapeutic application
unassigned |
1
0 |
